2 weeks Ago Ironwood Pharmaceuticals ( NASDAQ: IRWD ) received a notification letter on March 21, 2025 from Nasdaq indicating that, as a result of IRWD’s delay in filing its annual report for the year ended December 31, 2024 with the Securities and Exchange Commission, IRWD is not in.
